Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 21, 2017
Reporting Period: Event-based report for June 21, 2017.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report regarding a corporate event rather than a periodic financial report.
Material Changes
Intellectual Property Developments: On June 21, 2017, the Company announced the filing of two new patent applications. These applications cover data supporting:
- The use of immune system cells for the stimulation of perispinal angiogenesis to treat patients with lower back pain.
- Intradiscal stem cell administration for patients suffering from degenerative disc disease.
Guidance, Outlook, and Risks
Forward-Looking Statements: The press release furnished as Exhibit 99.1 contains forward-looking statements based on information available as of June 21, 2017. Management cautions that actual results may differ materially due to various factors.
Risk Factors: Investors are directed to the Company's Annual Report on Form 10-K for the year ended December 31, 2016, and subsequent SEC filings for a discussion of risk factors. The Company assumes no obligation to update forward-looking statements unless required by law.
Investor Verification Checklist
- Verify the status and scope of the two new patent applications filed on June 21, 2017.
- Review the full text of the press release (Exhibit 99.1) for specific details on the clinical data supporting the patent claims.
- Consult the Form 10-K for the year ended December 31, 2016, to understand the specific risk factors referenced in this filing.
- Check subsequent filings for any updates regarding the patent applications or clinical progress.